Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Pascal Biosciences Inc.
  6. Summary
    PAS   CA7024781089

PASCAL BIOSCIENCES INC.

(PAS)
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Bourse De Toronto
11/29/2021 11/30/2021 12/01/2021 12/02/2021 12/03/2021 Date
0.085(c) 0.085(c) 0.08(c) 0.08(c) 0.08 Last
46 000 61 000 126 394 5 000 0 Volume
-10.53% -0.00% -5.88% 0.00% 0.00% Change
More quotes
Estimated financial data (e)
Sales 2019 - - -
Net income 2019 -3,41 M -2,65 M -2,65 M
Net cash position 2019 0,36 M 0,28 M 0,28 M
P/E ratio 2019 -1,08x
Yield 2019 -
Sales 2020 - - -
Net income 2020 -1,24 M -0,96 M -0,96 M
Net Debt 2020 0,15 M 0,11 M 0,11 M
P/E ratio 2020 -7,16x
Yield 2020 -
Capitalization 5,21 M 4,07 M 4,05 M
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees 6
Free-Float 96,8%
More Financials
Company
Pascal Biosciences Inc. is a Canada-based biopharmaceutical company. The Company is engaged in the research and development of products for the treatment of cancers, and for improvement of the immune system. The Company operates in the segment of biotechnology research and development. The Company is focused on developing cannabinoid-based and targeted therapeutics to fight cancer. Its cannabinoid portfolio includes... 
More about the company
All news about PASCAL BIOSCIENCES INC.
11/26PASCAL BIOSCIENCES : Announces financing
PU
11/03UPDATE - InvestmentPitch Media Video Discusses Pascal Biosciences and its Non-Brokered ..
GL
11/03UPDATE - InvestmentPitch Media Video Discusses Pascal Biosciences and its Non-Brokered ..
GL
11/03InvestmentPitch Media Video Discusses Pascal Biosciences and its Award of a National Ca..
GL
11/03InvestmentPitch Media Video Discusses Pascal Biosciences and its Award of a National Ca..
GL
10/29Pascal Biosciences Announces Financing
AQ
10/28Pascal biosciences announces financing
PU
10/28Pascal Biosciences Inc. announced that it expects to receive CAD 0.9 million in funding
CI
10/22Pascal Biosciences Inc. Reports Earnings Results for the Third Quarter and Nine Months ..
CI
09/09PASCAL BIOSCIENCES : Addendum to rob gietl joins pascal biosciences as new chief executive..
AQ
09/07PASCAL BIOSCIENCES : Rob gietl joins pascal biosciences as new chief executive officer
PU
09/07Pascal Biosciences Inc. Appoints Rob Gietl as Chief Executive Officer
CI
09/07Pascal Biosciences Inc. Appoints Rob Gietl as President and Board of Director
CI
07/29Pascal Biosciences Inc. Reports Earnings Results for the Second Quarter Ended May 31, 2..
CI
06/16PASCAL BIOSCIENCES : Hardy Forzley Joins Pascal Biosciences As Chief Financial Officer
PU
More news
News in other languages on PASCAL BIOSCIENCES INC.
06/16Pascal Biosciences nomme un directeur financier
2020IRW-NEWS : Pascal Biosciences Inc.: Pascal Biosciences und SoRSE Technology gründen Partne..
More news
Chart PASCAL BIOSCIENCES INC.
Duration : Period :
Pascal Biosciences Inc. Technical Analysis Chart | PAS | CA7024781089 | MarketScreener
Income Statement Evolution
Managers and Directors
Rob Gietl President, Chief Executive Officer & Director
Harold Hardy Forzley Chief Financial Officer
Patrick W. Gray Chairman
Larry W. Tjoelker Vice President-Research
Terry W. Pearson Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PASCAL BIOSCIENCES INC.-36.00%4
GILEAD SCIENCES, INC.19.58%87 393
BIONTECH SE310.30%80 545
REGENERON PHARMACEUTICALS31.23%66 288
WUXI APPTEC CO., LTD.26.31%65 499
VERTEX PHARMACEUTICALS-13.49%51 982